Theriva Biologics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$18,349,000 over the previous period. Total operating expenses were $21,431,000.

Profit Margin

Theriva Biologics, Inc. (NYSE:TOVX): Profit margin
2014 0 -19.78M
2015 0 -43.73M
2016 0 -27.25M
2017 0 -15.17M
2018 0 -13.36M
2019 0 -15.02M
2020 0 -9.99M
2021 0 -14.17M
2022 0 -19.68M
2023 0 -18.34M

TOVX Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
135K268K87K201K240K0245K072K0
Gross profit
-135K-268K-87K-201K-240K0-245K0-72K0
Operating exp.
Research and development
14.31M11.72M7.8M5.13M11.08M11.84M18.78M29.10M32.90M14.48M
Selling and marketing
624K000000000
Total operating expenses
21.43M21.58M14.27M10.16M15.66M17.57M26.25M39.25M40.98M20.50M
Operating income
-21.43M-21.58M-14.27M-10.16M-15.66M-17.57M-26.25M-39.25M-40.98M-20.50M
Other income (expenses), net
1.44M471K6K44K283K4.08M10.75M11.41M-3.80M718K
Income before tax
-19.98M-21.11M-14.26M-10.11M-15.38M-13.42M-15.49M-27.80M-44.78M-19.78M
Income tax expense
-1.64M-1.42M-94K-117K-360K-4.20M-11.07M-11.99M2.75M-718K
Net income
-18.34M-19.68M-14.17M-9.99M-15.02M-13.36M-15.17M-27.25M-43.73M-19.78M
Earnings per share
Basic EPS
-28.49-1.28-1.16-5.26-9.14-21.45-42.7-101.17-189.68-111.78
Diluted EPS
-28.48-1.28-1.16-5.26-9.14-21.45-42.7-101.17-189.68-111.78
Data sourceData source